國立虎尾科技大學 |

Translational research in breast cancer = biomarker diagnosis, targeted therapies and approaches to precision medicine /

紀錄類型:	書目-語言資料,印刷品 : Monograph/item
正題名/作者:	Translational research in breast cancer/ edited by Erwei Song, Hai Hu.
其他題名:	biomarker diagnosis, targeted therapies and approaches to precision medicine /
其他作者:	Song, Erwei.
出版者:	Singapore :Springer Singapore : : 2017.,
面頁冊數:	viii, 418 p. :ill. (some col.), digital ; : 24 cm.;
Contained By:	Springer eBooks
標題:	Breast - Cancer. -
電子資源:	http://dx.doi.org/10.1007/978-981-10-6020-5
ISBN:	9789811060205

Translational research in breast cancer = biomarker diagnosis, targeted therapies and approaches to precision medicine /
Translational research in breast cancerbiomarker diagnosis, targeted therapies and approaches to precision medicine /[electronic resource] :edited by Erwei Song, Hai Hu. - Singapore :Springer Singapore :2017. - viii, 418 p. :ill. (some col.), digital ;24 cm. - Advances in experimental medicine and biology,v.10260065-2598 ;. - Advances in experimental medicine and biology ;780..

Chap. 1 The Dawning of Translational Breast Cancer: from Bench to Bedside -- Chap. 2 Biomarker Studies in Early Detection and Prognosis of Breast Cancer -- Chap. 3 The Preventive Intervention of Hereditary Breast Cancer -- Chap. 4 Predicting and Overcoming Chemotherapeutic Resistance for Breast Cancer -- Chap. 5 Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer -- Chap. 6 Targeted Therapies against Growth Factor Signaling in Breast Cancer -- Chap. 7 Targeting Stemness: Implications for Precision Medicine in Breast Cancer -- Chap. 8 Disrupting Tumor Angiogenesis and "the Hunger Games" for Breast Cancer -- Chap. 9 Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives -- Chap. 10 Perspectives of Reprogramming Breast Cancer Metabolism -- Chap. 11 Metabolic Changes during Cancer Cachexia Pathogenesis -- Chap. 12 Cell Cycle Regulation in Treatment of Breast Cancer -- Chap. 13 BRCA Gene Mutations and Poly (ADP-ribose) Polymerase Inhibitors in Triple-negative Breast Cancer -- Chap. 14 Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer -- Chap. 15 Progress in Vaccine Therapies for Breast Cancer -- Chap. 16 Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer -- Chap 17 New Approaches in CAR-T Cell Immunotherapy for Breast Cancer -- Chap 18 Immune Checkpoint Blockade in Breast Cancer Therapy.

This book offers a comprehensive introduction to translational efforts in breast cancer, addressing the latest approaches to precision medicine based on the current state of understanding of breast cancer. With the latest developments in breast cancer research, our understanding of the genomic changes and the oncogenic signaling cascade of breast cancer has made considerable strides. Further, the immuno-environment has been demonstrated as the barrier to clinical cancer. As a result of these two trends, a clearer picture of the molecular landscape of breast cancers has facilitated the development of diagnostic, prognostic and predictive biomarkers for clinical oncology. All these aspects are addressed in this volume, which offers a comprehensive resource for researchers, graduate students and oncologists in cancer research.

ISBN: 9789811060205

Standard No.: 10.1007/978-981-10-6020-5doiSubjects--Topical Terms:

678241
Breast
--Cancer.

LC Class. No.: RC280.B8

Dewey Class. No.: 616.99449

Translational research in breast cancer = biomarker diagnosis, targeted therapies and approaches to precision medicine /
LDR:03380nam a2200325 a 4500 001 922344
003 DE-He213
005 20171228024743.0
006 m d
007 cr nn 008maaau
008 190624s2017 si s 0 eng d
020 $a 9789811060205 $q (electronic bk.)
020 $a 9789811060199 $q (paper)
024 7 $a 10.1007/978-981-10-6020-5 $2 doi
035 $a 978-981-10-6020-5
040 $a GP $c GP
041 0 $a eng
050 4 $a RC280.B8
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99449 $2 23
090 $a RC280.B8 $b T772 2017
245 0 0 $a Translational research in breast cancer $h [electronic resource] : $b biomarker diagnosis, targeted therapies and approaches to precision medicine / $c edited by Erwei Song, Hai Hu.
260 $a Singapore : $c 2017. $b Springer Singapore : $b Imprint: Springer,
300 $a viii, 418 p. : $b ill. (some col.), digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1026
505 0 $a Chap. 1 The Dawning of Translational Breast Cancer: from Bench to Bedside -- Chap. 2 Biomarker Studies in Early Detection and Prognosis of Breast Cancer -- Chap. 3 The Preventive Intervention of Hereditary Breast Cancer -- Chap. 4 Predicting and Overcoming Chemotherapeutic Resistance for Breast Cancer -- Chap. 5 Studies on DNA Damage Repair and Precision Radiotherapy for Breast Cancer -- Chap. 6 Targeted Therapies against Growth Factor Signaling in Breast Cancer -- Chap. 7 Targeting Stemness: Implications for Precision Medicine in Breast Cancer -- Chap. 8 Disrupting Tumor Angiogenesis and "the Hunger Games" for Breast Cancer -- Chap. 9 Key Factors in Breast Cancer Dissemination and Establishment at the Bone: Past, Present and Future Perspectives -- Chap. 10 Perspectives of Reprogramming Breast Cancer Metabolism -- Chap. 11 Metabolic Changes during Cancer Cachexia Pathogenesis -- Chap. 12 Cell Cycle Regulation in Treatment of Breast Cancer -- Chap. 13 BRCA Gene Mutations and Poly (ADP-ribose) Polymerase Inhibitors in Triple-negative Breast Cancer -- Chap. 14 Targeting the Epigenome as a Novel Therapeutic Approach for Breast Cancer -- Chap. 15 Progress in Vaccine Therapies for Breast Cancer -- Chap. 16 Tumor Associated Macrophages as Therapeutic Targets for Breast Cancer -- Chap 17 New Approaches in CAR-T Cell Immunotherapy for Breast Cancer -- Chap 18 Immune Checkpoint Blockade in Breast Cancer Therapy.
520 $a This book offers a comprehensive introduction to translational efforts in breast cancer, addressing the latest approaches to precision medicine based on the current state of understanding of breast cancer. With the latest developments in breast cancer research, our understanding of the genomic changes and the oncogenic signaling cascade of breast cancer has made considerable strides. Further, the immuno-environment has been demonstrated as the barrier to clinical cancer. As a result of these two trends, a clearer picture of the molecular landscape of breast cancers has facilitated the development of diagnostic, prognostic and predictive biomarkers for clinical oncology. All these aspects are addressed in this volume, which offers a comprehensive resource for researchers, graduate students and oncologists in cancer research.
650 0 $a Breast $x Cancer. $3 678241
650 0 $a Breast $x Cancer $x Diagnosis. $3 644681
650 0 $a Breast $x Cancer $x Treatment. $3 678243
650 0 $a Biochemical markers. $3 582469
650 1 4 $a Biomedicine. $3 593880
650 2 4 $a Cancer Research. $3 668358
650 2 4 $a Cell Biology. $3 593889
700 1 $a Song, Erwei. $3 1111164
700 1 $a Hu, Hai. $3 1197870
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v 780. $3 881230
856 4 0 $u http://dx.doi.org/10.1007/978-981-10-6020-5
950 $a Biomedical and Life Sciences (Springer-11642)